Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 131

RapidSOS rescues $85m in series C round

The AAA, CSAA, Microsoft and Motorola Solutions-backed emergency response software developer’s latest round, led by Insight Partners, brought its total funding to $200m.

Feb 11, 2021

PGDx picks up $103m in series C

The round brought the total raised by the oncology diagnostics technology developer, backed by Bristol Myers Squibb, Helsinn and Inova Health, to $244m.

Feb 11, 2021

Notch marks $85m series A round

Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.

Feb 11, 2021

Drug Farm harvests $56m

The WuXi AppTec-backed round will help the hepatitis B drug developer begin human trials for its lead drug candidate.

Feb 11, 2021

SpyBiotech detects GV for series A round

GV returned for SpyBiotech's $32.5m series A round, as it looks to move its first potential vaccine into the clinic by early next year.

Feb 11, 2021

TransThera Biosciences takes in $50m

China Merchants Group participated in a series C-plus round for the cancer and inflammatory disease drug developer.

Feb 11, 2021

Evolve BioSystems revolves to series D

The probiotics developer secured an undisclosed amount as Cargill co-led the first close of a series D round with a $55m target.

Feb 11, 2021

IST Cube squares $48m fund

Vienna Insurance is among the limited partners for a $48m seed-stage fund aimed at university spinouts in Austria.

Feb 11, 2021

Sitka secures $14m in series A round

Optum Ventures returned to invest in the telehealth software developer’s series A round, which was led by Venrock.

Feb 11, 2021

Yuanxin organises $466m series E

Tencent co-led online health services provider Yuanxin Technology's series E round with fellow existing investor Sequoia Capital China.

Feb 9, 2021
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here